- Home
- NATH vs RCKT Comparison
NATH vs RCKT Comparison
Compare NATH & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATH
- RCKT
- Stock Information
- Founded
- NATH 1916
- RCKT 1999
- Country
- NATH United States
- RCKT United States
- Employees
- NATH N/A
- RCKT N/A
- Industry
- NATH Restaurants
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- NATH Consumer Discretionary
- RCKT Health Care
- Exchange
- NATH Nasdaq
- RCKT Nasdaq
- Market Cap
- NATH 385.4M
- RCKT 326.4M
- IPO Year
- NATH N/A
- RCKT N/A
- Fundamental
- Price
- NATH $110.24
- RCKT $2.70
- Analyst Decision
- NATH
- RCKT Buy
- Analyst Count
- NATH 0
- RCKT 13
- Target Price
- NATH N/A
- RCKT $18.50
- AVG Volume (30 Days)
- NATH 68.1K
- RCKT 8.4M
- Earning Date
- NATH 06-10-2025
- RCKT 08-04-2025
- Dividend Yield
- NATH 1.82%
- RCKT N/A
- EPS Growth
- NATH 22.29
- RCKT N/A
- EPS
- NATH 5.87
- RCKT N/A
- Revenue
- NATH $148,182,000.00
- RCKT N/A
- Revenue This Year
- NATH N/A
- RCKT N/A
- Revenue Next Year
- NATH N/A
- RCKT N/A
- P/E Ratio
- NATH $18.67
- RCKT N/A
- Revenue Growth
- NATH 6.91
- RCKT N/A
- 52 Week Low
- NATH $67.44
- RCKT $2.19
- 52 Week High
- NATH $118.50
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- NATH 56.67
- RCKT 32.09
- Support Level
- NATH $109.26
- RCKT $2.66
- Resistance Level
- NATH $112.90
- RCKT $3.33
- Average True Range (ATR)
- NATH 3.32
- RCKT 0.28
- MACD
- NATH -0.28
- RCKT 0.09
- Stochastic Oscillator
- NATH 43.71
- RCKT 26.59
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.